Our UAE team contribute to the 8th edition of the Life Sciences Law Review
Written By
The eighth edition of The Life Sciences Law Review covers a total of 33 jurisdictions, providing an overview of legal requirements of interest to pharmaceutical, biotechnology and medical device companies. The chapters are arranged so as to describe requirements throughout the life cycle of a regulated product, from discovery to clinical trials, the marketing authorisation process and post-approval controls.
Partner, Melissa Murray and Senior Associate, Surabhi Singhi provided content for the regulatory framework in the life sciences sector in the United Arab Emirates.
This article was first published by Law Business Research Ltd in April 2020.
Latest insights
More Insights
Balancing the candid disclosure of information to regulators, with the desire to maintain privilege: Recent developments regarding voluntary disclosure agreements
Apr 19 2024
Navigating the legal landscape of plastics – balancing utility with environmental responsibility
Apr 19 2024